A Large Scale Clinical Trial Testing the Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic Congestive Heart Failure
Phase of Trial: Phase III
Latest Information Update: 16 Aug 2015
At a glance
- Drugs Rosuvastatin (Primary) ; Omega-3-acid ethyl esters
- Indications Chronic heart failure; Heart failure
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Acronyms GISSI-HF
- 20 Nov 2013 Results for the prognostic impact of metabolic syndrome presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 20 Nov 2013 Pooled results for competing risks for fatal/non-fatal myocardial infarction (MI), fatal/non-fatal stroke, other CV death, and non-CV death presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 17 Nov 2013 Results of an analysis investigating the effect of bodyweight changes in outcomes presented at the 86th Annual Scientific Sessions of the American Heart Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History